2024-518104-47-00CompletedPhase 1
A clinical study of MK-2420 in healthy men (MK-2420-003)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 29 Nov 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- First submitted
- 31 Oct 2024
- Start date
- 19 Dec 2024
- Lead sponsor
- Merck Sharp & Dohme LLC
- EU CT number
- 2024-518104-47-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 48
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Ziekenhuis Gent | Gent | Belgium | Completed |
| UZ Leuven | Leuven | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.